Hydroxyamphetamine: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Hydroxyamphetamine. Educational only — not medical advice.
Labeled uses
PAREMYD® Solution is indicated for mydriasis in routine diagnostic procedures and in conditions where short-term pupil dilation is desired. PAREMYD® provides clinically significant mydriasis with partial cycloplegia.
Source: FDA labeling via NIH DailyMed (set da8a8a19…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.